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Abstract
The green peach aphid, Myzus persicae, is a globally distributed highly damaging crop pest. This species has
demonstrated an exceptional ability to evolve resistance to both synthetic insecticides used for control, and natural
insecticides produced by certain plants as a chemical defense against insect attack. Here we review work characterizing
the evolution of resistance in M. persicae to the natural insecticide nicotine and the structurally related class of syn-
thetic neonicotinoid insecticides. We outline how research on this topic has provided insights into long-standing ques-
tions of both evolutionary and applied importance. These include questions pertaining to the origins of novel traits, the
number and nature of mutational events or ‘adaptive steps’ underlying the evolution of new phenotypes, and whether
host plant adaptations can be co-opted to confer resistance to synthetic insecticides. Finally, research on the molecular
mechanisms underlying insecticide resistance in M. persicae has generated several outstanding questions on the
genetic architecture of resistance to both natural and synthetic xenobiotics, and we conclude by identifying key
knowledge gaps for future research.
© 2021 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
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1 INTRODUCTION
The green peach aphid, Myzus persicae (Sulzer, 1776), is an eco-
nomically important crop pest that feeds on over 400 plant spe-
cies, including many agricultural and ornamental plants.1 The
species causes damage to plants through direct feeding, the pro-
duction of honeydew and the transmission of over 100 plant
viruses.2, 3 The control of M. persicae on many crops has relied
heavily on the use of chemical insecticides, and their intensive
use over many years has led to the development of widespread
and multiple forms of resistance.3, 4 Research on the biochemical
and molecular basis of resistance in M. persicae has uncovered at
least eight genetically independent mechanisms of resistance,
making it an important case study for molecular evolution in
insects.3, 5 In addition to developing resistance to synthetic insec-
ticides, M. persicae is also adept at evolving resistance to natural
xenobiotics, such as the secondary metabolites produced by
plants as defense against herbivores. The best example of this is
the host race associated with tobacco (Nicotiana tabacum), for-
mally named as M. persicae subsp. nicotianae.6 This subspecies
exhibits resistance to the alkaloid nicotine, the potent natural
insecticide produced by tobacco, and intriguingly, cross-
resistance to neonicotinoid insecticides - synthetic derivatives of
nicotine.7 Both nicotine and neonicotinoids act as agonists of nic-
otinic acetylcholine receptors (nAChRs); pentameric ion channels
that play a key role in signal transduction between nerve cells.8
However, while nicotine exhibits high affinity towards both verte-
brate and invertebrate nAChRs, neonicotinoids show high affinity
only for invertebrate receptors.8
Over the last decade, understanding of the genetic architec-
ture that underpins the key adaptations that allow M. persicae
to effectively tolerate nicotine and neonicotinoid insecticides
has advanced considerably. Here we review this work and con-
sider how this case study has provided knowledge for both
applied aspects of direct relevance to pest management, and
more widely for fundamental questions in evolutionary
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biology. Finally, we identify outstanding knowledge gaps for
future research.
2 THE GENETIC ARCHITECTURE OF
RESISTANCE TO NICOTINE
2.1 Cytochrome P450s belonging to the CYP6CY
subfamily confer resistance to nicotine
Because the host shift ofM. persicae to tobacco occurred recently,
direct comparisons of adapted and nonadapted conspecific races
offer an excellent opportunity to identify the mechanisms leading
to nicotine resistance. Gene expression microarrays were first
used to compare the transcriptomes of M. p. nicotianae and
M. persicae s.s., and identified the cytochrome P450 gene CYP6CY3
as highly overexpressed in the former.9 Further study confirmed
the causal role of this P450 in resistance by demonstrating that
recombinant CYP6CY3 is highly efficient at metabolizing nicotine
to less toxic metabolites in vitro, compared with the primary
human nicotine-metabolizing P450 CYP2A6.7 This findingwas fur-
ther supported by the demonstration in vivo that ectopic expres-
sion of CYP6CY3 in transgenic Drosophila results in significant
desensitization to nicotine.7
Initial investigation of the mechanisms leading to the overex-
pression of CYP6CY3 revealed that enhanced mRNA levels of this
P450 gene in M. p. nicotianae result, in part, from amplification
of the structural gene.9 Subsequent publication of the first refer-
ence genomes for M. persicae10 allowed a more detailed genetic
investigation of the CYP6CY3 amplification event.11 These ana-
lyses revealed that, in M. p. nicotianae, CYP6CY3 is amplified
3–5-fold (at its native loci) as a tandem array of direct repeats of
approximately 325 Kb, adding up to 1.5 Mb to chromosome 3.11
The large genomic region amplified encompasses several
genes in addition to CYP6CY3, including two other genes
belonging to the CYP6CY subfamily (CYP6CY4 and CYP6CY23),
the tyrosine-protein kinase gene Src42A, a gene encoding a
voltage-dependent T-type calcium channel, the last 23 exons of
A disintegrin and metalloproteinase with thrombospondin motifs
9 (ADAMTS9), and the first two exons of the 40S ribosomal protein
S11 (RPS11) gene.11 Furthermore, as the segmental duplication
occurs as a direct tandem repeat, the chromosomal rearrange-
ment also created a chimeric gene at the junctions between
amplicon copies, fusing the regions of the RPS11 and ADAMTS9
genes that occur at the amplicon breakpoints.11 The discovery
that multiple genes are co-amplified with CYP6CY3 raised the pos-
sibility that resistance to nicotine may also, in part, result from the
increased gene dosage of other genes in the amplicon. Investiga-
tion of this hypothesis uncovered evidence that, for some of these
genes, enhanced expression may be neutral or deleterious, with
nonfunctionalizing mutations observed in certain copies of
Src42A and the T-type calcium channel gene, that lead to their
inactivation.11 Furthermore, transgenic Drosophila strains expres-
sing either wild-type ADAMTS9 or the chimeric RPS11/ADAMTS9
gene showed no increase in tolerance to nicotine compared to
flies of the same genetic background lacking a transgene, sug-
gesting they provide no protection to M. p. nicotianae from
nicotine.11
The three CYP6CY P450 genes within the amplicon share
72–81% amino acid sequence identity, explaining the very high
estimates of CYP6CY3 copy number in tobacco-adapted clones
in early studies using primers that cross-hybridize between these
genes.7, 9, 11 Functional expression of CYP6CY4 and CYP6CY23
in vitro revealed that CYP6CY4, but not CYP6CY23, can efficiently
metabolize nicotine to it's nontoxic metabolite cotinine.11 Thus,
together with the earlier functional characterization of CYP6CY3,
these studies provide convincing evidence that increased expres-
sion of CYP6CY3 and CYP6CY4 allowed M. p. nicotianae to over-
come the primary defensive allelochemical produced by
tobacco plants.
2.2 Regulation of resistance
2.2.1 Microsatellite repeats and further increases in
CYP6CY3 CNV
CYP6CY3 and CYP6CY4 are upregulated as a result of their amplifi-
cation as part of the large segmental duplication. However,
despite their parity in copy number at this loci, RNA-seq analysis
revealed that the expression of CYP6CY3 is more than double that
of CYP6CY4 in M. p. nicotianae.11 This observation suggested
that additional mutations that occurred before or after the large
segmental duplication may have further elevated CYP6CY3
expression. In this regard, early work reporting the amplification
of CYP6CY3 also identified a polymorphic AC(n) dinucleotide
microsatellite in the putative CYP6CY3 promoter, comprising
15 repeat units inM. persicae s.s., but increasing to 48 repeat units
inM. p. nicotianae.7 Functional investigation of this polymorphism
demonstrated that this change results in a doubling of the expres-
sion of a reporter gene in vitro,7 and thus likely, in part, explains
the enhanced expression of CYP6CY3 relative to CYP6CY4. Further-
more, sequence analysis revealed that all copies of CYP6CY3 have
the microsatellite expansion, suggesting that it predates the
amplification event. Subsequent investigation revealed that
the expression of CYP6CY3 is likely further enhanced as a result
of additional duplication of this gene outside the large segmental
duplication. Specifically, a copy of CYP6CY3 was identified in M. p.
nicotianae at a novel locus located on a small (14 Kb) amplicon at
least 1.5 Mb away from the native locus.11 Intriguingly, two DNA
transposons, belonging to the hAT (hobo-Ac-Tam3) and Tc1/mari-
ner superfamilies, were also found within the 14 Kb amplicon, nei-
ther of which are observed in M. persicae s.s. at this position.11
These transposon sequences occur downstream of CYP6CY3 and
adjacent to the 50 break point, suggesting they were involved in
the mobilization of CYP6CY3 to the new loci, either indirectly by
acting as substrates for nonallelic homologous recombination or
directly via alternative transposition.11
2.2.2 Trans- and post-transcriptional regulation of CYP6CY3
In addition to characterization of the cis-regulation of CYP6CY3,
recent work has also begun to investigate its trans- and post-
transcriptional regulation. CYP6CY3 expression in M. p. nicotianae
has been shown to be induced (2-fold upregulated) following
exposure to 250 μM nicotine.12 This suggests regulatory regions
within or flanking the CYP6CY3 gene contain xenobiotic respon-
sive elements that are activated by trans-acting factors involved
in xenobiotic signal transduction. Related to this, investigation
of potential trans-regulators of CYP6CY3 has provided evidence
of regulation by the bHLH/PAS transcription factor Aryl hydrocar-
bon Receptor (AhR), which binds to Aryl Hydrocarbon Receptor
Nuclear Translocator (ARNT) to form an active heterodimer.13 Pro-
moter pull down assays, together with reporter gene assays of the
CYP6CY3 promoter with or without the two bHLH/PAS proteins,
suggested they regulate its transcription.13 In the same study
AhR and ARNTwere identified as overexpressed inM. p. nicotianae
compared toM. persicae s.s.13 However, only a singleM. p. nicotia-
nae clone and two M. persicae s.s. clones were used in this study,
and transcriptome profiling of a larger number of clones of each
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subspecies failed to identify AhR/ARNT as consistently upregu-
lated in the tobacco-adapted subspecies.11 Thus, the importance
of the upregulation of these transcription factors in enhancing
CYP6CY3 expression in M. p. nicotianae remains unclear.
The post-transcriptional regulation of CYP6CY3 has been inves-
tigated by sequencingmicroRNAs (miRNAs), a class of non-coding
RNAs that play important roles in post-transcriptional gene regu-
lation.14 This identified the miRNAs let-7 and mir-100 as downre-
gulated in a single clone of M. p. nicotianae compared to two
M. persicae s.s. clones.14 Chemical inhibition of these miRNAs
was shown to increase CYP6CY3 expression and decrease suscep-
tibility to nicotine suggesting they play a role in its regulation.14
Thus, further investigation of the role of these miRNAs in the reg-
ulation of CYP6CY3 in a greater number of M. p. nicotianae and
M. persicae s.s. clones is required.
2.2.3 Qualitative changes in CYP6CY3 expression
Work on the regulation of CYP6CY3 has also served as an excellent
illustration that qualitative changes in gene expression can be
equally, or even more important, than quantitative changes in
enhancing organismal fitness during adaptation to novel condi-
tions. Immunohistochemistry, RNAseq and qPCR analyses
revealed that the primary site of CYP6CY3 expression in
M. persicae s.l. are the bacteriocytes, representing a previously
undescribed tissue-specific expression pattern for an insect
P450.11 Bacteriocytes are specialized aphid cells that house the
obligate bacterial endosymbiont Buchnera aphidicola, which pro-
vides essential amino acids and other nutrients to its host that it
does not obtain from its phloem food source.15 Nicotine has
strong antimicrobial properties that extend to Gram-negative
bacteria such as Escherichia coli, the closest free-living relative of
B. aphidicola.16, 17 Assessment of B. aphidicola titre following expo-
sure ofM. persicae s.s. andM. p. nicotianae to a diet containing nic-
otine suggested that enhanced levels of CYP6CY3 expression in
M. p. nicotianae may protect B. aphidicola from nicotine's inhibi-
tory effects.11 In addition to the enhanced expression of CYP6CY3
in aphid bacteriocytes, expression analyses further identified the
gut as a second site of high expression exclusively inM. p. nicotia-
nae, with CYP6CY3mRNA levels in this tissue >2500-fold higher in
M. p. nicotianae than in M. persicae s.s.11 This remodulation of
CYP6CY3 expression in the gut of M. p. nicotianae would provide
a first line of defense against nicotine ingested during feeding,
preventing or delaying it reaching nAChRs in the aphid nervous
system. Thus, the pattern of spatial expression of CYP6CY3 reveals
an innovative evolutionary solution, that ensured both the aphid
host and its essential symbiont were protected against the pri-
mary anti-herbivore defense of tobacco (Fig. 1). In contrast to
the tissue-specific expression of CYP6CY3, no clear pattern of
tissue-specific expression of CYP6CY4 was observed.11 Together
with the lower levels of expression of this P450 relative to
CYP6CY3, this finding suggests that overexpression of this P450
may play a secondary role in metabolizing nicotine in tissues out-
side the gut and bacteriocyte that are exposed to this toxin.
Genomic investigation of the mutations leading to the dramatic
increase in CYP6CY3 expression in the gut by long single-molecule
sequencing of the CYP6CY3 gene locus identified a remarkable
series of TE insertions, occurring individually or in combination,
in close proximity to amplified copies of the CYP6CY3 gene.11 In
addition to the hAT and Tc1/mariner elements described above,
these included a transposon with high sequence similarity to
the TTAA3_AP element of Acyrthosiphon pisum, and a fourth
transposon belonging to the Mutator-like element (MULE)
superfamily of DNA transposons.11 Transposable element inser-
tions in regulatory regions of P450 genes have been previously
shown to lead to both quantitative and qualitative changes in
expression.18, 19 In regards to the latter, examination of the spatial
expression of the four elements flanking CYP6CY3 revealed that, in
bothM. persicae andM. p. nicotianae, all are highly and specifically
expressed in the gut.11 Thus, while further experimental valida-
tion is required, these TE insertions may have played a role in
qualitative changes in the expression of CYP6CY3 by bringing
tissue-specific enhancer sequences into close proximity with this
P450 gene.
In summary, the evolution of resistance to nicotine inM. p. nico-
tianae appears to have involved a complex series of mutational
events that resulted in profound qualitative and quantitative
changes in the expression of P450 genes that can detoxify this
toxin. These are outlined in Fig. 2 together with their predicted
order of occurrence, based on sequence characterization of the
genomic loci involved.
3 CO-OPTION OF A RESISTANCE TRAIT
Resistancemonitoring ofM. persicae s. l. conducted since the com-
mercial launch of the first neonicotinoid, imidacloprid, in Europe
and USA consistently showed that tobacco-derived clones exhibit
increased tolerance to this insecticide.20–24 Subsequent studies
demonstrated that this resistance extends to other neonicotinoid
insecticides.25 This finding, together with the structural similarity
and shared mode of action of nicotine and neonicotinoids, led
to the hypothesis that the evolution of resistance to nicotine in
M. p. nicotianae may have preadapted this subspecies to resist
neonicotinoids.23 The discovery of CYP6CY3 overexpression in
M. p. nicotianae allowed this hypothesis to be tested, with func-
tional expression demonstrating that this P450 does indeed
metabolize the neonicotinoids imidacloprid and clothianidin to
less toxic metabolites in vitro, and confers resistance to the latter
in vivo.7 Subsequent stable expression of CYP6CY3 in Drosophila
S2 cells confirmed that CYP6CY3 is active against imidacloprid
and clothianidin, as well as acetamiprid and thiacloprid, but had
no activity against dinotefuran.26 Furthermore, and importantly,
CYP6CY3 overexpression was identified in two M. p. nicotianae
clones collected prior to the introduction of neonicotinoids, dem-
onstrating that the mutations leading to the amplification of
CYP6CY3 predate the use of these insecticides.7 Taken together,
these findings unequivocally indicate that CYP6CY3 overexpres-
sion did not arise as a result of selection from the use of neonico-
tinoid insecticides, but rather that this mechanism evolved during
adaptation to tobacco, preadaptingM. p. nicotianae to resist neo-
nicotinoid insecticides.
CYP6CY3 metabolizes neonicotinoids significantly less effi-
ciently than nicotine,7 and the levels of resistance conferred by
its overexpression are modest,7, 21 thus the implications of this
mechanism for control of M. p. nicotianae using this insecticide
class are unclear. Tests of the efficacy of the neonicotinoid imida-
cloprid against M. p. nicotianae and M. persicae s.s. clones under
simulated field conditions showed that both subspecies were well
controlled when imidacloprid was applied at the recommended
field rate.21 However, M. p. nicotianae was more likely to survive
and reproduce when this compound was applied at lower con-
centrations.21 Such conditions can arise in neonicotinoid-treated
crops from the natural break down of the insecticide over time,
or its application at rates below those recommended for aphid
control, either as a mechanism to cut costs or to target non-aphid
Molecular innovations underlying resistance www.soci.org
Pest Manag Sci 2021 © 2021 The Authors.
Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
wileyonlinelibrary.com/journal/ps
3
pests present in the crop.21 Thus, CYP6CY3 overexpression may
provide fitness benefits in neonicotinoid-treated crops that select
for this mechanism. If this is the case then an increase in fre-
quency of this mechanism in M. persicae s.l. following the intro-
duction of neonicotinoids might be expected, potentially as a
result of its transfer fromM. p. nicotianae toM. persicae s.s. Recent
population genomic analyses of 127 M. persicae s.l. aphid clones
collected from multiple host plants around the world has pro-
vided strong evidence that selection from neonicotinoid use
may indeed have been sufficiently strong for this to have
occurred.5 CYP6CY3 amplification was found to be ubiquitous in
globally sampled clones collected from tobacco, providing further
confirmation of the importance of this mechanism in enabling
M. p. nicotianae to exploit this host plant.5 However, CYP6CY3
amplification was also observed at high frequency in clones
derived from several other host plants.5 This suggests that the fit-
ness benefits conferred by this mutation extend beyond nicotine
resistance, with its pleiotropic effects on neonicotinoid insecticide
sensitivity the most likely explanation. Investigation of the num-
ber of evolutionary origins of this mutation revealed that the
mechanism of CYP6CY3 amplification is identical in all clones,
regardless of geographical origin.5 This suggests that CYP6CY3
amplification had a single origin in M. p. nicotianae, with this
mechanism subsequently spreading to M. persicae s.s. around
the world following the introduction of neonicotinoids. Thus,
the ability of CYP6CY3 amplification to confer reduced sensitivity
to neonicotinoids, previously a co-incidental pleiotropic effect,
appears to have become the major selective force driving the
geographic spread of this trait.
4 STANDING GENETIC VARIATION
COMBINES WITH DE NOVO MUTATION TO
CONFER POTENT NEONICOTINOID
RESISTANCE
The fact that M. persicae s.l. clones overexpressing CYP6CY3 can
be controlled when neonicotinoids are applied at recommended
rates,21 provided strong selection for any novel mutations that, in
isolation or in combination with CYP6CY3 overexpression, led to
more potent neonicotinoid resistance. This scenario was realized
20 years after the launch of neonicotinoids with the discovery of
a clone of M. persicae that exhibited potent resistance to this
insecticide class, easily sufficient to compromise their field effec-
tiveness.27 This clone was found to carry the mutations leading
to CYP6CY3 overexpression, in combination with a novel muta-
tion in the ⊎1 subunit of the nAChR that resulted in an arginine
to threonine substitution (R81T).27 Importantly the amino acid at
this position occurs in a region that forms the binding site for
the natural ligand acetylcholine and agonists such as neonicoti-
noids, and is a key determinant of neonicotinoid selectivity for
insect nAChRs.28, 29 Specifically the positively charged arginine
usually present at this position in insects forms electrostatic inter-
actions with the distinctive electronegative pharmacophore (nitro
(A) (C)
(B)
Figure 1. Schematic of the mutations leading to resistance to nicotine and neonicotinoid insecticides in M. persicae. (A) Schematic of an aphid showing
the primary site of entry (the gut) and action (the nicotinic acetylcholine receptor (nAChR) in the central nervous system (CNS)) of nicotine and neonico-
tinoid insecticides. Nicotine also has antimicrobial properties that extend to Gram-negative bacteria such as Escherichia coli, which is the closest free-living
relative of the obligate endosymbiont Buchnera aphidicola residing in specialized aphid cells called bacteriocytes. (B) Chromosomal rearrangements result
in the increased expression of CYP6CY3 and CYP6CY4 which detoxify nicotine (and in the case of CYP6CY3 certain neonicotinoids). In the case of CYP6CY3
expression is significantly enhanced in bacteriocytes and reprogrammed to include the aphid gut providing two lines of defence that protectM. p. nico-
tianae and its symbiont fromnicotine. The high expression of CYP6CY3 in the gut also confers cross-resistance to neonicotinoids. (C) Subsequentmutation
(R81T) of the nAChR leads to a reduction in neonicotinoid binding at the receptor, and, in concert with CYP6CY3 overexpression, potent resistance to sev-
eral members of this insecticide class.
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or cyano group) of neonicotinoid insecticides.27–29 In contrast, in
the case of vertebrate ⊎ subunits these interactions do not form
as the amino acid at this position rarely has a positive charge, with
a threonine the most common residue observed.27–29 Thus, the
R81T mutation appears to reduce the sensitivity of the nAChR to
neonicotinoids by conferring a ‘vertebrate-like’ quality to the ⊎1
subunit of resistant aphids.27 Recently, the causal role of R81T in
conferring resistance to neonicotinoids was further confirmed
by CRISPR-CAS genome editing of D. melanogaster.30 This work
also demonstrated that R81T is inherited as an incompletely
recessive trait in Drosophila,30 consistent with the dominance sta-
tus of this mutation reported for M. persicae.31
Intriguingly, since its discovery, the R81Tmutation has only ever
been observed in clones displaying CYP6CY3 amplification.3, 5 This
suggests that this mutation emerged on a genetic background of
CYP6CY3 overexpression, and the two mechanisms together pro-
vide strong fitness benefits against neonicotinoids. Support for
this hypothesis has come from two studies. Firstly, co-application
of neonicotinoids and the P450 inhibitor piperonyl butoxide to
aphids carrying CYP6CY3 overexpression + R81T resulted in a
reduction of resistance of up to approximately 9-fold, suggesting
a strong P450-mediated component to resistance.27 Secondly,
introduction of R81T into D. melanogaster by genome editing
resulted in transgenic flies with resistance phenotypes of only
6.5- and 32.6-fold for acetamiprid and imidacloprid, respec-
tively.30 Thus, the modest levels of resistance conferred by this
mutation in isolation is unlikely to fully explain the >1000-fold
resistance factors observed in M. persicae clones that carry
R81T in combination with CYP6CY3 amplification.27 While fur-
ther experimental work is required using the native species,
taken together these findings suggest that the evolution of
resistance to neonicotinoids in M. persicae represents an adap-
tive walk. In this case, the sequential emergence of novel ben-
eficial mutations comprised a metabolic mechanism arising
during adaptation to tobacco followed by target site alteration.
Individually, available evidence suggests these confer modest
levels of resistance, however, in concert they appear to act syn-
ergistically to confer potent resistance to neonicotinoids. In this
regard, recent studies of transgenic Drosophila lines expressing
insecticide metabolizing P450 enzymes of insect crop pests
and disease vectors in a genetic background containing
target-site resistance mutations has provided clear evidence
that these mechanisms may often act synergistically to confer
strong resistance.32
Finally, given that R81T is spreading through M. persicae s.l.







Figure 2. Schematic of mutational events at the CYP6CY3 locus. (A) Initial genetic modification of the locus included the expansion of an
AC(n) microsatellite repeat in the promoter of CYP6CY3 and the insertion of a hAT transposable element downstream of this gene. (B) A region of approx-
imately 350 Kb in size was then amplified as a series of three to five direct repeats, increasing the copy number of all the genes in the amplicon and cre-
ating a chimeric gene (RPS11/ADAMTS9). Further remodeling of the 30 region of CYP6CY3 continued with the insertion of a TTAA3 element into one of the
copies of CYP6CY3 (C). A ∼ 14 Kb region encompassing CYP6CY3 in combination with the hAT and TTAA3 elements was then copied to a new location on
the same chromosome (D), after which it was furthermodified by the insertion of Tc1/mariner element into the existing hAT sequence (E). Remarkably, the
latter process appears to have been repeated in the case of the original CYP6CY3 copy at the native locus but in this case a MULE transposon inserted into
the hAT sequence (F). Additional genes included in the 350 Kb insertion and then silenced are not shown for clarity.
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movement of this mechanism intoM. p. nicotianae provides addi-
tional fitness advantages to this subspecies on tobacco by confer-
ring higher levels of resistance to nicotine. In this case, a
mechanism that appears to have evolved to resist synthetic insec-
ticides would be recruited to provide additional protection
against a natural xenobiotic, demonstrating that the co-option
of resistance mechanisms can occur in both directions.
5 EVOLUTIONARYANDAPPLIED INSIGHTS
The detailed molecular characterization of resistance in
M. persicae to natural and synthetic insecticides outlined in this
review provides insights of relevance to both fundamental
understanding of the evolutionary processes mediating adap-
tation to novel conditions and applied aspects of pest and
resistance management. In this section we briefly outline some
of the key fundamental and applied questions this work has
informed.
5.1 How many and what type of mutational events or
‘adaptive steps’ underpin adaptive phenotypes?
The molecular investigation of resistance to nicotine inM. p. nico-
tianae has uncovered a remarkable catalogue of mutations in the
genomes of resistant clones (Fig. 2). As described above these
include: (i) expansion of microsatellite repeats in gene regulatory
regions, (ii) large and small gene duplications that increase the
gene dosage of single or multiple genes, (iii) nonfunctionalizing
mutations that inactivate amplified gene copies that provide no
fitness benefit, and (iv) transposable element insertions that
may have been involved in gene duplication events and funda-
mental changes in gene regulation. Collectively, these findings
demonstrate that the evolution of even a relatively simple pheno-
type (resistance to nicotine) can be underpinned by a remarkable
diversity of mutational events. They also provide new insights into
the mechanisms by which genetic variation is created, and show
that profound genetic alterations, such as chromosomal rearran-
gements and transposable element insertions, can provide a rich
and dynamic source of raw material for adaptation. Indeed, the
extensive genetic variation created by these processes may pro-
vide greater opportunities for saltatory evolution than stepwise
adaptation involving point mutations. The progression of muta-
tions uncovered in this case study also serves as a reminder of
the complex processes sometimes involved in adaption. Specifi-
cally, the finding that large-scale gene amplification was followed
by remodeling to eliminate gene copies that provide no fitness
benefit, illustrates how the journey through fitness landscapes
can involve the creation of genetic by-products in the form of
pseudogenes.
5.2 What is the relative contribution of quantitative
versus qualitative divergence during the evolution of
novel traits?
Study of the role of CYP6CY3 in resistance has shown that while
mutations leading to quantitative changes in gene expression
are unquestionably important, in some cases, qualitative changes
in gene expression may be just as, or perhaps more, important in
conferring the novel phenotype (resistance). Specifically, the pro-
found remodeling of CYP6CY3 expression to include the aphid gut
created a first line of defense against nicotine ingested during
feeding.11 Furthermore, the enhanced expression of this P450 in
the specialized cells housing the obligate bacterial symbiont
B. aphidicola appears to have provided additional protection
against the antimicrobial properties of nicotine.11 Thus, both qual-
itative and quantitative changes in CYP6CY3 expression were
likely key to ensure the fitness of an essential mutualistic
symbiosis was preserved during an insect host shift. Although fur-
ther experimental confirmation is required, these studies also
further implicate the potential role of transposable elements in
mediating transcriptional regulation by bringing tissue-specific
enhancer sequences in close proximity to key resistance
genes.11, 35
5.3 What are the origins of resistance traits? Can
mechanisms that have evolved to overcome natural
xenobiotics be recruited to resist synthetic insecticides?
An important question of applied relevance to pest and resistance
management is the extent to which mechanisms arising during
insect host plant adaptation can be co-opted to confer resistance
to synthetic insecticides. Research on the tobacco-adapted sub-
species M. p. nicotianae has provided a compelling example that
this can occur, with the evolution of mechanisms to overcome
the plant alkaloid nicotine preadapting this subspecies to resist
neonicotinoids, a globally important class of insecticide. Neonico-
tinoids and nicotine exhibit similarity in chemical structure, and
the active site of CYP6CY3 is thus able to accommodate both
plant and man-made insecticides.3, 7 The observed cross-
resistance of M. p. nicotianae to these compounds demonstrates
that existing detoxification systems can be co-opted to protect
insects from insecticides if sufficient similarity exists between
their natural substrate(s) and the synthetic compound in ques-
tion. This finding also highlights the inherent risk of resistance
development to insecticidal compounds that share chemical sim-
ilarity with natural compounds encountered by herbivorous
insects.
5.4 Does resistance to synthetic insecticides arise by de
novo mutation or from standing variation?
As noted above, work on M. persicae has shown that the pleiotro-
pic effects of existing adaptations to natural compounds can
result in their selection by synthetic insecticides. In this context
the polymorphisms leading to CYP6CY3 overexpression repre-
sented standing genetic variation, that is, the polymorphisms
were already present in the population prior to the change in
selective pressure (the introduction of neonicotinoid insecticides).
The levels of neonicotinoid resistance conferred by this mecha-
nism are modest, and thus subsequent de novo mutation was
required to provide M. persicae with greater protection to this
insecticide class. Intriguingly, these mechanisms have only ever
been observed in combination and appear to act synergistically
to confer potent resistance.3, 5, 27, 30 This suggests that standing
genetic variation provided a platform (i.e. suitable genetic back-
ground) for further evolution by de novo mutation. Indeed, the
low levels of resistance conferred by the R81T mutation alone,30
and its synergistic interaction with CYP6CY3 overexpression,27
suggest that the probability of R81T surviving loss via stochastic
processes while still rare was enhanced by its emergence in a
genetic background of CYP6CY3 overexpression. This research
also demonstrates that the evolution of insecticide resistance
from standing genetic variation and by de novo mutation are
not necessarily mutually exclusive, and both sources of variability
can act together to provide resistance. This is significant as the rel-
ative contribution of de novomutations and standing variation in
resistant phenotypes has a number of implications of relevance to
resistance management and risk assessment including
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repeatability, probability and speed of emergence, and spread of
resistance mutations.36 Finally, it is predicted that de novo adapta-
tions to sudden environmental change emerge rapidly, whereas
standing variation accumulates over a longer time scale.36 The lat-
ter may allow rarer genetic changes to occur and more complex
traits to evolve.36 The mechanisms of M. persicae resistance to
neonicotinoids is consistent with these predictions, with the
standing variation in this case comprising a complex suite of
mutations, in contrast with the single nucleotide alteration arising
by de novo mutation.
5.5 To what extent do the findings described for
M. persicae in this review extend to other insect and mite
pest species?
Many of the processes and insights into resistance evolution
described for M. persicae have parallels with recent research con-
ducted on other arthropods. In the case of the genetic architec-
ture of insecticide resistance, while resistance in pest
populations directly derived the field, appears to be primarily
driven by single genes/mutations of large effect, other, more
complex cases have been described. For example in Drosophila
melanogaster DDT resistance is conferred by overexpression of
the P450 gene Cyp6g1.37 Elegant work investigating the upregula-
tion of this gene uncovered successive mutations at the Cyp6g1
locus, including copy number increases and multiple transpos-
able element insertions in the 50 regulatory region of the gene.38
Importantly, this sequence of mutations was shown to lead to
step-wise increases in DDT resistance.38 Further potential parallels
of the work on Cyp6g1 with that of M. persicae CYP6CY3 relate to
qualitative changes in gene expression. Specifically, cis-regulatory
elements present in the transposable elements in the promoter
region of Cyp6g1 increased its expression in tissues important
for detoxification such as the midgut, Malpighian tubules, and
the fat body.35 Changes in gene copy number have also been
shown to lead to insecticide resistance in a range of other arthro-
pod pests, in some cases involving large segmental duplica-
tions.39 For example, the ace-1 gene (encoding the target of
organophosphate and carbamate insecticides) was shown to be
amplified with 11 other genes as an amplicon of 203 kb in the
mosquito Anopheles gambiae.40 Furthermore, as seen at the
CYP6CY3 locus of M. persicae, intra-amplicon deletions were iden-
tified at the ace-1 locus that occurred after the duplication that
reduced the cost of dosage imbalance for the genes co-amplified
with ace-1.40 Taken together, these studies clearly illustrate the
important role of transposable elements and gene duplication/
amplification in the evolution of insecticide resistance, and dem-
onstrate that these mechanisms are not exclusive to aphids.
The link between adaptation to plant secondary metabolites
and resistance to synthetic insecticides described for M. persicae
is complemented by work on this topic in other generalist pest
herbivores, and more recently, non-pest species. For example,
recent studies on the glasshouse whitefly and spider mites have
shown that transfer of these species to a range of different host
plants results in profound changes in gene expression
(up to 20% of genes) including in genes encoding detoxification
enzymes.41, 42 Remarkably, these changes in gene expression
are associated with significant shifts in the tolerance of host-
adapted lines to synthetic insecticides.41, 42 Together these find-
ings extend the work on CYP6CY3 ofM. persicae by demonstrating
that induced as well as constitutive changes in the expression of
detoxification genes during host plant adaptation can lead to
changes in tolerance to synthetic insecticides. In the case of
non-pest species, work on bee pollinators has provided additional
evidence that the metabolic systems used by insects to detoxify
the natural toxins encountered in their environment can preadapt
them to tolerate certain synthetic insecticides. Specifically, in
honey bees (Apis mellifera), bumblebees (Bombus terrestris) and
red mason bees (Osmia bicornis) P450 enzymes belonging to the
CYP9Q and CYP9BU subfamilies were shown to provide protection
to certain insecticides from three different classes including N-
cyanoamidine neonicotinoids.43–45 Thus these insecticides must
be sufficiently similar to the native substrates of these enzymes
to allow them to be metabolized. In this regard, although the
diversity of natural substrates that these P450 subfamilies can
metabolize has not been characterized, all members of the CYP9Q
subfamily in honeybees can metabolize the plant secondary
metabolite quercetin with high efficiency, a flavonoid that is pre-
sent in pollen and nectar.46
Finally, in relation to the evolutionary origins of insecticide resis-
tance, the findings on M. persicae are consistent with other
insects, where cases of evolution by either de novo mutation or
selection from standing variation have been described.36 Exam-
ples of resistance evolution via a combination of both standing
variation and de novo mutation, such as in the case of neonicoti-
noid resistance in M. persicae, appear to be much rarer. However,
work on the genetics of resistance to organophosphate
(OP) insecticides in the sheep blowfly, Lucilia cuprina, has pro-
vided another example that the two origins are not mutually
exclusive.47, 48 In this case resistance to the OP insecticides diazi-
non and malathion is conferred by mutations at two sites
(G137N and W251L/S/T) in the Lc⊍7 gene encoding the esterase
E3 enzyme.47, 48 While, one of these (G137N) was only identified
in samples collected after the introduction of diazinon, suggest-
ing it evolved by de novo mutation, mutations at the second site
(W251) were identified in preserved specimens collected prior to
the first use of OPs, providing unambiguous evidence of their
presence as standing genetic variation in populations of
L. cuprina.47, 48
6 KNOWLEDGE GAPS AND FUTURE
RESEARCH
While the work detailed in this review has advanced understand-
ing of the molecular mechanisms of xenobiotic resistance, a num-
ber of unanswered questions on the genetic architecture of
resistance in M. persicae remain and provide numerous avenues
for future research. These are briefly summarized below.
While the causal role of CYP6CY3 and CYP6CY4 in nicotine resis-
tance in M. p. nicotianae has been established, it is possible that
other genes contribute either directly or indirectly. Specifically,
further investigation of the role of the RPS11/ADAMTS9 chimeric
gene inM. p. nicotianae is warranted, to clarify if it provides any fit-
ness benefits on tobacco or if it represents a neutral polymor-
phism retained because of its close linkage to other genes in the
amplicon that are under positive selection. The finding that trans-
genic lines of D. melanogaster expressing the chimeric gene
remain sensitive to nicotine is inconsistent with a direct role in
resistance.11 However, the high expression of RPS11/ADAMTS9
in M. p. nicotianae and absence of nonfunctionalizing mutations
in its coding sequence is intriguing, and suggests it might provide
alternative fitness benefits on tobacco within its native genetic
background.11 Similarly, transcriptomic analyses identified a glu-
tathione S-transferase (GST) belonging to the sigma class as signif-
icantly downregulated inM. p. nicotianae compared toM. persicae
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s.s.11 GSTs are dimeric enzymes that are most commonly known
for their role in cellular detoxification - catalyzing the conjugation
of glutathione (GSH) to a wide range of endogenous and
xenobiotic agents.49 However, the downregulation of the GST in
M. p. nicotianae is not consistent with a fitness benefit via a direct
role in metabolism, and future work could explore potential
non-enzymatic roles in adaptation to nicotine/tobacco. Recent
advances in the development of CRISPR-CAS genome editing for
the pea aphid, Acyrthosiphon pisum, offer a promising avenue
for further investigation of the functional characterization of these
candidate genes.50 However, the difficulties associated with the
generation and crossing of sexual stages, and the number and
development time of eggs produced in M. persicae remain obsta-
cles for future adoption of this technology.
The discoveries made on the amplification and regulation of
CYP6CY3 and CYP6CY4 have also generated further questions
and topics for future research. Firstly, the precise mechanisms
leading to the large segmental duplication at the native
CYP6CY3/4 locus remain unresolved. Changes in gene copy num-
ber can result from non-allelic homologous recombination, non-
homologous end joining and/or via the activity of transposable
elements.51 The recent publication of two chromosome-scale
genome assemblies for M. persicae provides a new opportunity
to investigate the role of these processes in the amplification of
CYP6CY3/4.5, 52 The remarkable expression profile of CYP6CY3 in
M. persicae s.s. and M. p. nicotianae also merits further detailed
investigation. The expression of this P450 in the aphid bacterio-
cyte in both subspecies11 is unprecedented, and its native
role(s) in this specialized tissue is unclear. Further functional ana-
lyses are also required to identify the mutations leading to the
profound modifications in the tissue-specific expression of
CYP6CY3 in the tobacco-adapted subspecies.11 In particular, the
role of the numerous transposable element insertions occurring
in close proximity to CYP6CY3 in activating expression in the gut
requires confirmatory work. More widely, the diverse impacts of
transposable elements on host genomic complexity and evolu-
tion are now well-established,19, 53 and transposons are increas-
ingly implicated in resistance evolution.54, 55 Consequently,
transposon load may directly affect the evolvability of pest line-
ages, particularly when under strong selection, with accompany-
ing implications for insecticide resistance and control. Thus,
more research is required to examine the extent to which mobile
genetic elements are important players in resistance evolution.
Work on these topics will likely also provide further insight into
the trans-acting factors that regulate CYP6CY3.
In terms of neonicotinoid resistance, the precise level of resis-
tance conferred by target-site andmetabolic mechanisms individ-
ually and in combination inM. persicae remains uncertain, and this
could be investigated using a conventional genetics approach or
by CRISPR-CAS genome editing. Similarly, the impact of R81T and
CYP6CY3 overexpression in isolation on the efficacy of control in
the field using neonicotinoids remains to be defined for many
crops where this insecticide class is widely used. It would also be
interesting to examine the fitness of clones carrying the R81T
mutation on tobacco to establish if this mechanism provides addi-
tional advantages to those conferred by CYP6CY3/4 overexpres-
sion. This could also reveal if a resistance mechanism resulting
from anthropogenic activity may be co-opted to enhance fitness
against a plant defensive compound.
Finally, work is required to establish whether the resistance
mechanisms described in this review carry fitness costs in the
absence of insecticide selection. In particular, the >2500-fold
increase in expression of CYP6CY3 in the aphid gut would be
envisaged to incur a significant metabolic cost. Investigation of
this topic may also benefit from novel genome editing
approaches as these can facilitate fitness comparisons of clones
that share the same genetic background but differ in the presence
of a specific resistance mechanism.56 Knowledge generated by
such studies is of significant applied value as fitness penalties
may result in the restoration of susceptibility to an insect popula-
tion in the absence of selection, whichmay be exploited in control
and resistant management strategies.
7 CONCLUSION
Over the last decade the development of next generation
sequencing technologies and associated post-genomic functional
approaches have allowed investigation of the molecular mecha-
nisms involved in resistance to natural and synthetic insecticides
at unprecedented resolution. In the case of M. persicae, this has
revealed the remarkable array of both large-scale and subtle
genetic alterations that can be selected by insecticide exposure.
Research has illustrated the value of investigation of resistance
in providing fundamental insights into the molecular processes
by which genetic variation is created and used in the emergence
of novel traits. In turn, a mechanistic understanding of resistance
evolution has provided knowledge of applied relevance that can
be used to inform the design of resistance risk assessments and
strategies that aim to prevent, contain or overcome resistance.
Finally, this work has generated a range of questions and topics
for further investigation providing multiple avenues for exciting
research in the years ahead.
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